Provided by Tiger Trade Technology Pte. Ltd.

Cardiff Oncology, Inc.

1.47
+0.160012.21%
Volume:1.80M
Turnover:2.55M
Market Cap:114.18M
PE:-2.49
High:1.47
Open:1.42
Low:1.36
Close:1.31
52wk High:3.31
52wk Low:0.7566
Shares:77.67M
Float Shares:75.24M
Volume Ratio:4.75
T/O Rate:2.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5914
EPS(LYR):-0.6863
ROE:-94.08%
ROA:-46.73%
PB:4.30
PE(LYR):-2.14

Loading ...

Cardiff Oncology - Onvansertib Safe and Well-Tolerated With No New Toxicities Added to Soc

THOMSON REUTERS
·
Jun 02

Cardiff Oncology Announces Presentation of Positive Results From Its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line Ras-Mutated Mcrc at the 2026 Asco Annual Meeting

THOMSON REUTERS
·
Jun 02

Cardiff Oncology - Phase 2 Trial Achieves Primary Goal Selecting Onvansertib Dose for Registration

THOMSON REUTERS
·
Jun 02

Kazia Therapeutics names James Levine CFO effective June 1

Reuters
·
Jun 02

Cardiff Oncology to present at Jefferies Global Healthcare Conference

Reuters
·
Jun 02

Cardiff Oncology Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Jun 01

Cardiff Oncology Inc : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
Jun 01

HC Wainwright Downgrades Cardiff Oncology to Neutral From Buy

MT Newswires Live
·
Jun 01

U.S. RESEARCH ROUNDUP-Palomar Holdings, Replimune Group, Snowflake

Reuters
·
Jun 01

BRIEF-Cardiff Oncology - Nms Informs Cardiff Oncology Of Agreement Termination On May 27, 2026

Reuters
·
May 30

Cardiff Oncology - Nms Alleges Cardiff Oncology Breached Agreement Over Cardiff Patents Inventorship - SEC Filing

THOMSON REUTERS
·
May 30

Cardiff Oncology sues Nerviano Medical Sciences over onvansertib license dispute

Reuters
·
May 30

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardiff Oncology (CRDF), ACADIA Pharmaceuticals (ACAD) and Immunic (IMUX)

TIPRANKS
·
May 22

Cardiff Oncology updates Phase 2 onvansertib data in first-line RAS-mutated mCRC trial

Reuters
·
May 22

Cardiff Oncology Sues Nerviano As Analyst Backs Onvansertib Defense

Benzinga
·
May 21

Cardiff Oncology Inc - Seeks Injunctive Relief and Declaratory Judgment in Lawsuit Against Nms - SEC Filing

THOMSON REUTERS
·
May 20

Cardiff Oncology Inc - Files Lawsuit Against Nerviano Medical Sciences Over Breach of Onvansertib License Agreement - SEC Filing

THOMSON REUTERS
·
May 20

Cardiff Oncology sues Nerviano Medical Sciences over onvansertib license dispute

Reuters
·
May 20

Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL) and Cardiff Oncology (CRDF)

TIPRANKS
·
May 19

Cardiff Oncology (CRDF) Gets a Buy from H.C. Wainwright

TIPRANKS
·
May 15